Francisco Javier Cubero

Francisco Javier Cubero

Francisco Javier Cubero
Cargo

Professor of Immunology in the Department of Immunology, Ophthalmology and ENT of the Complutense University of Madrid, member of the Gregorio Marañón Health Research Institute of Madrid and the Networked Biomedical Research Center for Liver and Digestive Diseases (CIBEREHD)

Topics

Only 5% of therapies studied in animals are ever approved for use in humans

Five out of ten potential treatments move from animal studies to human studies; four to randomised controlled clinical trials; and one in 20 moves on to approval by regulatory agencies, an analysis estimates. Concordance between positive results in animals and in clinical studies is 86%, according to the study, published in PLoS Biology, which pools the findings of 122 published studies on 54 different human diseases.  

0